Cynthia Sirard's most recent trade in Compass Therapeutics Inc was a trade of 1,000,000 STOCK OPTION (RIGHT TO BUY) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Compass Therapeutics Inc | Cynthia Sirard | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 1,000,000 | 1,000,000 | - | - | STOCK OPTION (RIGHT TO BUY) | |
| Leap Therapeutics Inc | Cynthia Sirard | Chief Medical Officer | 28 Mar 2025 | 22,500 | 0 | - | - | Restricted Stock Units | ||
| Leap Therapeutics Inc | Cynthia Sirard | Chief Medical Officer | 28 Mar 2025 | 22,500 | 27,500 (0%) | 0% | - | Common Stock | ||
| Leap Therapeutics Inc | Cynthia Sirard | Chief Medical Officer | 02 Oct 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Leap Therapeutics Inc | Sirard Cynthia | Chief Medical Officer | 29 Jan 2024 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Leap Therapeutics Inc | Cynthia Sirard | Chief Medical Officer | 26 Jan 2024 | 5,000 | 5,000 (0%) | 0% | - | Common Stock | ||
| Leap Therapeutics Inc | Sirard Cynthia | Chief Medical Officer | 26 Jan 2024 | 5,000 | 0 | - | - | Restricted Stock Units | ||
| Leap Therapeutics Inc | Cynthia Sirard | Chief Medical Officer | 23 Aug 2023 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Leap Therapeutics Inc | Cynthia Sirard | Chief Medical Officer | 31 Mar 2023 | 500,000 | 500,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Leap Therapeutics Inc | Cynthia Sirard | Chief Medical Officer, Ten Percent Owner | 31 Jan 2022 | 225,000 | 225,000 | - | - | Restricted Stock Units |